touchRESPIRATORY were delighted to talk with Dr Ronald Strauss (Cleveland Allergy and Asthma Center; Case Western Reserve University Medical School, Cleveland, OH, USA) around his analysis of the association of eosinophilia with improved COVID-19 outcomes in patients treated with inhaled corticosteroids.
The abstract ‘Eosinophilia is Associated with Improved COVID-19 Outcomes in Patients Treated with Inhaled Corticosteroids.’ was presented at AAAAI 2022, 25-28 February.
Questions
- What is known about the relationship between eosinophilia and COVID-19 outcomes? (0:19)
- What was the rationale for the analysis you are presenting? (0:56)
- What were the findings of this analysis? (1:44)
- What questions remain unanswered and what future studies are planned? (3:38)
Disclosures: Ronald Strauss has nothing to disclose in relation to this video.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Victoria Jones.
Filmed in coverage of the AAAAI meeting 2022.
